newsfilter
← Latest News
Business Wire·

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

  • bioAffinity Technologies, Inc. will host a webinar on July 21, 2026, featuring an expert panel to discuss mobile CT screening, noninvasive CyPath® Lung testing, & comprehensive functional lung imaging for veterans.
  • The National Association of Veterans' Research and Education Foundations (NAVREF) will organize the event to address lung health challenges, including toxic exposures recognized under the PACT Act.
  • Moderator Rashi Romanoff will lead a panel including Amy Rohs, MD (Philips), Michael Nicholson, DO (RWJBarnabas Health), & Greg Mogel, MD (4DMedical).
  • Dr. Nicholson will present clinical data on CyPath® Lung, a noninvasive test using flow cytometry & AI to detect malignancy in sputum with reported 92% sensitivity & 99% negative predictive value.
  • Dr. Mogel will discuss 4DMedical's advanced imaging solutions for assessing lung structure & function to enable earlier detection of respiratory diseases.
  • The webinar aims to demonstrate how emerging diagnostic technologies can reduce costs, improve access, & enhance early detection outcomes for veterans at high risk for lung cancer.
  • The event is scheduled for 6 p.m. ET/5:00 p.m. CT on July 21, 2026, & is intended for healthcare professionals in pulmonary medicine, oncology, radiology, & veteran health services.